Voloridge Investment Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $70.4M | Buy |
+180,681
| New | +$76.4M | 0.3% | 90 |
|
|
2026
Q1 | – | Sell |
-1,690
| Closed | -$789K | – | 1119 |
|
|
2025
Q4 | $789K | Buy |
+1,690
| New | +$785K | ﹤0.01% | 1032 |
|
|
2025
Q1 | – | Sell |
-169,622
| Closed | -$50.9M | – | 1250 |
|
|
2024
Q4 | $50.9M | Sell |
169,622
-31,553
| -16% | -$11M | 0.18% | 160 |
|
|
2024
Q3 | $81.8M | Sell |
201,175
-5,601
| -3% | -$2.05M | 0.3% | 77 |
|
|
2024
Q2 | $66.4M | Buy |
206,776
+79,152
| +62% | +$25.7M | 0.25% | 108 |
|
|
2024
Q1 | $42.6M | Buy |
+127,624
| New | +$39M | 0.16% | 190 |
|
|
2023
Q4 | – | Sell |
-156,111
| Closed | -$38.4M | – | 1288 |
|
|
2023
Q3 | $38.4M | Sell |
156,111
-111,131
| -42% | -$30.4M | 0.19% | 144 |
|
|
2023
Q2 | $81.1M | Buy |
267,242
+80,894
| +43% | +$22.5M | 0.38% | 51 |
|
|
2023
Q1 | $49.1M | Buy |
+186,348
| New | +$47.3M | 0.24% | 113 |
|
|
2022
Q4 | – | Sell |
-3,821
| Closed | -$702K | – | 1519 |
|
|
2022
Q3 | $702K | Sell |
3,821
-475,127
| -99% | -$94.7M | ﹤0.01% | 1219 |
|
|
2022
Q2 | $80.5M | Buy |
478,948
+390,038
| +439% | +$83.8M | 0.42% | 45 |
|
|
2022
Q1 | $22.3M | Sell |
88,910
-78,030
| -47% | -$19.6M | 0.13% | 234 |
|
|
2021
Q4 | $42.9M | Buy |
166,940
+93,590
| +128% | +$22.9M | 0.23% | 103 |
|
|
2021
Q3 | $17.8M | Sell |
73,350
-8,943
| -11% | -$2.19M | 0.11% | 235 |
|
|
2021
Q2 | $17M | Buy |
+82,293
| New | +$16.8M | 0.12% | 224 |
|
|
2020
Q4 | – | Sell |
-66,309
| Closed | -$8.27M | – | 1419 |
|
|
2020
Q3 | $8.27M | Sell |
66,309
-435,998
| -87% | -$54M | 0.07% | 306 |
|
|
2020
Q2 | $48.8M | Buy |
502,307
+484,634
| +2,742% | +$50.4M | 0.56% | 31 |
|
|
2020
Q1 | $1.59M | Buy |
+17,673
| New | +$2.29M | 0.05% | 406 |
|
|
2019
Q2 | – | Sell |
-20,626
| Closed | -$2.69M | – | 881 |
|
|
2019
Q1 | $2.69M | Sell |
20,626
-27,734
| -57% | -$3.72M | 0.08% | 240 |
|
|
2018
Q4 | $6.02M | Sell |
48,360
-83,228
| -63% | -$11.2M | 0.27% | 98 |
|
|
2018
Q3 | $18.3M | Buy |
131,588
+43,538
| +49% | +$5.42M | 0.4% | 78 |
|
|
2018
Q2 | $9.03M | Buy |
88,050
+29,277
| +50% | +$2.96M | 0.24% | 99 |
|
|
2018
Q1 | $5.7M | Buy |
+58,773
| New | +$5.7M | 0.13% | 137 |
|
|
2015
Q3 | – | Sell |
-151,418
| Closed | -$13.7M | – | 329 |
|
|
2015
Q2 | $13.7M | Buy |
151,418
+24,949
| +20% | +$2M | 0.7% | 33 |
|
|
2015
Q1 | $9.51M | Sell |
126,469
-126,161
| -50% | -$9.06M | 0.46% | 62 |
|
|
2014
Q4 | $18.5M | Buy |
252,630
+239,431
| +1,814% | +$16.8M | 1.09% | 13 |
|
|
2014
Q3 | $931K | Buy |
+13,199
| New | +$872K | 0.04% | 85 |
|
Other funds holding HCA
Voloridge Investment Management's HCA Position: Q2 2026 in Review
Voloridge Investment Management opened a new position in HCA Healthcare (HCA) in Q2 2026: 180,681 shares worth $70.4M. The stake represents 0.3% of the portfolio and ranks #90 among its holdings. This is a return to the name: Voloridge Investment Management previously reported a position in HCA as recently as Q4 2025.
Voloridge Investment Management first reported a position in HCA in Q3 2014 and has held it in 27 quarters since. The position peaked at $81.8M in Q3 2024. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Voloridge Investment Management held 180,681 shares of HCA Healthcare worth $70.4M as of Q2 2026.
- HCA Healthcare was a new Voloridge Investment Management position in Q2 2026.
- HCA Healthcare made up 0.3% of Voloridge Investment Management's portfolio in Q2 2026, its #90 holding.
- Voloridge Investment Management first reported a position in HCA Healthcare in Q3 2014 and has held it in 27 quarters since.
- Voloridge Investment Management's HCA Healthcare position peaked at $81.8M in Q3 2024.
- 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.